Freenome, Inc. Current Liabilities
Freenome, Inc. (FRNM) had Current Liabilities of $3.63 million as of 2026-06-30, per its S-1 filed 2026-08-18.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-18
- 2026-06-30: Liabilities, Current $3.63M.
- 2026-03-31: Liabilities, Current $2.86M.
- 2025-12-31: Liabilities, Current $2.25M.
- 2025-09-30: Liabilities, Current $934.56K.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $3.63M S-1 · filed 2026-08-18 |
| 2026-03-31 | $2.86M S-4/A · filed 2026-06-11 |
| 2025-12-31 | $2.25M S-1 · filed 2026-08-18 |
| 2025-09-30 | $934.56K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $281.15K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $265.57K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $210.81K S-1 · filed 2026-08-18 |
| 2024-09-30 | $159.98K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $28.36K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |